Literature DB >> 32789766

Glucose transporters in brain in health and disease.

Hermann Koepsell1.   

Abstract

Energy demand of neurons in brain that is covered by glucose supply from the blood is ensured by glucose transporters in capillaries and brain cells. In brain, the facilitative diffusion glucose transporters GLUT1-6 and GLUT8, and the Na+-D-glucose cotransporters SGLT1 are expressed. The glucose transporters mediate uptake of D-glucose across the blood-brain barrier and delivery of D-glucose to astrocytes and neurons. They are critically involved in regulatory adaptations to varying energy demands in response to differing neuronal activities and glucose supply. In this review, a comprehensive overview about verified and proposed roles of cerebral glucose transporters during health and diseases is presented. Our current knowledge is mainly based on experiments performed in rodents. First, the functional properties of human glucose transporters expressed in brain and their cerebral locations are described. Thereafter, proposed physiological functions of GLUT1, GLUT2, GLUT3, GLUT4, and SGLT1 for energy supply to neurons, glucose sensing, central regulation of glucohomeostasis, and feeding behavior are compiled, and their roles in learning and memory formation are discussed. In addition, diseases are described in which functional changes of cerebral glucose transporters are relevant. These are GLUT1 deficiency syndrome (GLUT1-SD), diabetes mellitus, Alzheimer's disease (AD), stroke, and traumatic brain injury (TBI). GLUT1-SD is caused by defect mutations in GLUT1. Diabetes and AD are associated with changed expression of glucose transporters in brain, and transporter-related energy deficiency of neurons may contribute to pathogenesis of AD. Stroke and TBI are associated with changes of glucose transporter expression that influence clinical outcome.

Entities:  

Keywords:  Brain; Diabetes; GLUT1; GLUT1 deficiency syndrome; GLUT2; GLUT3; GLUT4; Glucose transporter; Parkinson’s disease; SGLT1; Stroke; Traumatic brain injury

Mesh:

Substances:

Year:  2020        PMID: 32789766      PMCID: PMC7462931          DOI: 10.1007/s00424-020-02441-x

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  470 in total

1.  Imino sugars are potent agonists of the human glucose sensor SGLT3.

Authors:  Andrew A Voss; Ana Díez-Sampedro; Bruce A Hirayama; Donald D F Loo; Ernest M Wright
Journal:  Mol Pharmacol       Date:  2006-11-16       Impact factor: 4.436

2.  Acute upregulation of blood-brain barrier glucose transporter activity in seizures.

Authors:  E M Cornford; E V Nguyen; E M Landaw
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-09       Impact factor: 4.733

3.  Subcellular distribution of glucose transporter (GLUT-1) during development of the blood-brain barrier in rats.

Authors:  S Bolz; C L Farrell; K Dietz; H Wolburg
Journal:  Cell Tissue Res       Date:  1996-06       Impact factor: 5.249

4.  Contribution of vasogenic and cellular edema to traumatic brain swelling measured by diffusion-weighted imaging.

Authors:  P Barzó; A Marmarou; P Fatouros; K Hayasaki; F Corwin
Journal:  J Neurosurg       Date:  1997-12       Impact factor: 5.115

5.  Uptake and metabolism of fructose by rat neocortical cells in vivo and by isolated nerve terminals in vitro.

Authors:  Bjørnar Hassel; Ahmed Elsais; Anne-Sofie Frøland; Erik Taubøll; Leif Gjerstad; Yi Quan; Raymond Dingledine; Frode Rise
Journal:  J Neurochem       Date:  2015-03-13       Impact factor: 5.372

6.  Metabolic profile of the hippocampus of Zucker Diabetic Fatty rats assessed by in vivo 1H magnetic resonance spectroscopy.

Authors:  Marinette van der Graaf; Susan W J Janssen; Jack J A van Asten; Ad R M M Hermus; C G J Sweep; Jeroen A Pikkemaat; Gerard J M Martens; Arend Heerschap
Journal:  NMR Biomed       Date:  2004-10       Impact factor: 4.044

7.  O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.

Authors:  Fei Liu; Khalid Iqbal; Inge Grundke-Iqbal; Gerald W Hart; Cheng-Xin Gong
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

8.  Influence of insulin in the ventromedial hypothalamus on pancreatic glucagon secretion in vivo.

Authors:  Sachin A Paranjape; Owen Chan; Wanling Zhu; Adam M Horblitt; Ewan C McNay; James A Cresswell; Jonathan S Bogan; Rory J McCrimmon; Robert S Sherwin
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

9.  Altered angioarchitecture in selected areas of brains with Alzheimer's disease.

Authors:  V W Fischer; A Siddiqi; Y Yusufaly
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

10.  T1R3 and gustducin in gut sense sugars to regulate expression of Na+-glucose cotransporter 1.

Authors:  Robert F Margolskee; Jane Dyer; Zaza Kokrashvili; Kieron S H Salmon; Erwin Ilegems; Kristian Daly; Emeline L Maillet; Yuzo Ninomiya; Bedrich Mosinger; Soraya P Shirazi-Beechey
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-27       Impact factor: 11.205

View more
  59 in total

Review 1.  Astrocytes in depression and Alzheimer's disease.

Authors:  Yang Liao; Qu Xing; Qianqian Li; Jing Zhang; Ruiyuan Pan; Zengqiang Yuan
Journal:  Front Med       Date:  2021-11-23       Impact factor: 4.592

2.  Neuroprotective effects of Canagliflozin: Lessons from aged genetically diverse UM-HET3 mice.

Authors:  Hashan S M Jayarathne; Lucas K Debarba; Jacob J Jaboro; Brett C Ginsburg; Richard A Miller; Marianna Sadagurski
Journal:  Aging Cell       Date:  2022-06-15       Impact factor: 11.005

3.  Basic physiology of the blood-brain barrier in health and disease: a brief overview.

Authors:  Mehmet Kaya; Bulent Ahishali
Journal:  Tissue Barriers       Date:  2020-11-15

4.  Starvation-induced regulation of carbohydrate transport at the blood-brain barrier is TGF-β-signaling dependent.

Authors:  Helen Hertenstein; Ellen McMullen; Astrid Weiler; Anne Volkenhoff; Holger M Becker; Stefanie Schirmeier
Journal:  Elife       Date:  2021-05-25       Impact factor: 8.140

5.  Peripheral Insulin Regulates a Broad Network of Gene Expression in Hypothalamus, Hippocampus, and Nucleus Accumbens.

Authors:  Weikang Cai; Xuemei Zhang; Thiago M Batista; Rubén García-Martín; Samir Softic; Guoxiao Wang; Alfred K Ramirez; Masahiro Konishi; Brian T O'Neill; Jong Hun Kim; Jason K Kim; C Ronald Kahn
Journal:  Diabetes       Date:  2021-05-24       Impact factor: 9.337

Review 6.  Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease.

Authors:  Pascual Sanz; José Maria Serratosa; Marina P Sánchez
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

7.  Integrated network analysis identifying potential novel drug candidates and targets for Parkinson's disease.

Authors:  Pusheng Quan; Kai Wang; Shi Yan; Shirong Wen; Chengqun Wei; Xinyu Zhang; Jingwei Cao; Lifen Yao
Journal:  Sci Rep       Date:  2021-06-23       Impact factor: 4.379

8.  Identification of new GLUT2-selective inhibitors through in silico ligand screening and validation in eukaryotic expression systems.

Authors:  Sina Schmidl; Oleg Ursu; Cristina V Iancu; Mislav Oreb; Tudor I Oprea; Jun-Yong Choe
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379

Review 9.  Advancing Diabetic Retinopathy Research: Analysis of the Neurovascular Unit in Zebrafish.

Authors:  Chiara Simone Middel; Hans-Peter Hammes; Jens Kroll
Journal:  Cells       Date:  2021-05-25       Impact factor: 6.600

10.  Polychlorinated biphenyls induce oxidative stress and metabolic responses in astrocytes.

Authors:  Mondona S McCann; Harvey R Fernandez; Sarah A Flowers; Kathleen A Maguire-Zeiss
Journal:  Neurotoxicology       Date:  2021-07-12       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.